MAPT and Alzheimer disease: Soluble total tau concentrations were highest in the very youngest DS cases (0–2 years of age) and steadily decreased with patient age until after age 30 (R2=0.42, p<0.0001; Additional file 2: Supplementary Fig. 2c), but on average were not significantly different to those in AD or ADNC (Fig. 2f).